Author: GlobeNewswire

Two new executive positions created in connection with departure of R&D HeadNEW YORK and DURHAM, N.C., Oct. 21, 2021 (GLOBE…

FLORHAM PARK, N.J., Oct. 21, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel…

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies,…

AUSTIN, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for…

SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…

Management to host conference call today at 5:00 p.m. ETAUSTIN, Texas, Oct. 21, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc.…

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for…

REDWOOD CITY, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise…

Expands International Commercialization with Initial Shipment of T2Dx Instruments to AsiaLEXINGTON, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) — T2 Biosystems,…

SANTA MONICA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines…